Clinical trial
Phase 2 Study of Fetal Growth Retardation Treatment by Sildenafil
NCT01107782 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of Fetal Growth Retardation Treatment by Sildenafil
- Lead sponsor
- Tehran University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- June 30, 2008
- Completion date
- January 31, 2012
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.